FindTrial
Sign In

Clinical trial of sirolimus in treatment of refractory vascular malformations.

Clinical trial of sirolimus in treatment of refractory vascular malformations.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-15006722
Enrollment
Unknown
Registered
2015-07-07
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory vascular malformations

Interventions

Sirolimus treatment group:Use sirolimus for treatment

Sponsors

Children‘s Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Children with refractory vascular malformations

Exclusion criteria

Exclusion criteria: Children with immune deficiency and infection

Design outcomes

Primary

MeasureTime frame
boold routine test;Coagulation function;Tumor size;—

Countries

China

Contacts

Public ContactLi Kai
likai2727@163.com+86 18017591001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026